These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 7796668)

  • 21. Characterization of two infectious mouse mammary tumour viruses: superantigenicity and tumorigenicity.
    Buggiano V; Goldman A; Nepomnaschy I; Bekinschtein P; Berguer P; Lombardi G; Deroche A; Francisco MV; Piazzon I
    Scand J Immunol; 1999 Mar; 49(3):269-77. PubMed ID: 10102644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neonatal impaired response to viral superantigen encoded by MMTV(SW) and Mtv-7.
    Le Bon A; Desaymard C; Papiernik M
    Int Immunol; 1995 Dec; 7(12):1897-903. PubMed ID: 8746559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transgenic mouse mammary tumor virus superantigen expression prevents viral infection.
    Golovkina TV; Chervonsky A; Dudley JP; Ross SR
    Cell; 1992 May; 69(4):637-45. PubMed ID: 1316806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maternal transfer of infectious mouse mammary tumor retroviruses does not depend on clonal deletion of superantigen-reactive V beta 14+ T cells.
    Penninger JM; Wallace VA; Timms E; Mak TW
    Eur J Immunol; 1994 May; 24(5):1102-8. PubMed ID: 8181521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transfer of endogenous retroviral superantigen from donor to recipient B cells following priming to induce peripheral T cell tolerance.
    Modlin CS; Todd GT; Cohen TD; Fairchild RL
    Cell Immunol; 1995 Sep; 164(2):217-26. PubMed ID: 7656330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regions of mouse mammary tumor virus superantigen involved in interaction with the major histocompatibility complex class II I-A molecule.
    Wirth S; Vessaz A; Krummenacher C; Baribaud F; Acha-Orbea H; Diggelmann H
    J Virol; 2002 Nov; 76(21):11172-5. PubMed ID: 12368363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New infectious mammary tumor virus superantigen with V beta-specificity identical to staphylococcal enterotoxin B (SEB).
    Luther S; Shakhov AN; Xenarios I; Haga S; Imai S; Acha-Orbea H
    Eur J Immunol; 1994 Aug; 24(8):1757-64. PubMed ID: 8056034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD28/CTLA4-B7 interaction is dispensable for T cell stimulation by mouse mammary tumor virus superantigen but not for B cell differentiation and virus dissemination.
    Champagne E; Scarpellino L; Lane P; Acha-Orbea H
    Eur J Immunol; 1996 Jul; 26(7):1595-602. PubMed ID: 8766566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Superantigens and retroviral infection: insights from mouse mammary tumor virus.
    Held W; Acha-Orbea H; MacDonald HR; Waanders GA
    Immunol Today; 1994 Apr; 15(4):184-90. PubMed ID: 8198710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Initial stages of mammary tumor virus infection are superantigen independent.
    Pobezinskaya Y; Chervonsky AV; Golovkina TV
    J Immunol; 2004 May; 172(9):5582-7. PubMed ID: 15100301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo effects of a recombinant vaccinia virus expressing a mouse mammary tumor virus superantigen.
    Krummenacher C; Diggelmann H; Acha-Orbea H
    J Virol; 1996 May; 70(5):3026-31. PubMed ID: 8627779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Superantigen-induced immune stimulation amplifies mouse mammary tumor virus infection and allows virus transmission.
    Held W; Waanders GA; Shakhov AN; Scarpellino L; Acha-Orbea H; MacDonald HR
    Cell; 1993 Aug; 74(3):529-40. PubMed ID: 8394220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T cells bearing Vbeta8 are preferentially infected with exogenous mouse mammary tumor virus.
    Upragarin N; Nishimura H; Wajjwalku W; Ando Y; Nagafuchi S; Watanabe T; Yoshikai Y
    J Immunol; 1997 Sep; 159(5):2189-95. PubMed ID: 9278306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Coevolutive mechanisms between retroviruses and their hosts. The murine mammary tumor model].
    Nepomnaschy I; Buggiano V; Goldman A; Piazzon I
    Medicina (B Aires); 1997; 57(2):235-44. PubMed ID: 9532836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Viral superantigens].
    Us D
    Mikrobiyol Bul; 2016 Jul; 50(3):491-504. PubMed ID: 27525406
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel exogenous mammary tumor virus encoding MHC class II H2E-independent superantigen specific for Tcr-V beta 14.
    Wajjwalku W; Ando Y; Niimi N; Yoshikai Y
    Immunogenetics; 1995; 41(2-3):156-8. PubMed ID: 7806290
    [No Abstract]   [Full Text] [Related]  

  • 37. The bacterial and mouse mammary tumor virus superantigens; two different families of proteins with the same functions.
    Marrack P; Winslow GM; Choi Y; Scherer M; Pullen A; White J; Kappler JW
    Immunol Rev; 1993 Feb; 131():79-92. PubMed ID: 8387458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A V beta 4-specific superantigen encoded by a new exogenous mouse mammary tumor virus.
    Maillard I; Erny K; Acha-Orbea H; Diggelmann H
    Eur J Immunol; 1996 May; 26(5):1000-6. PubMed ID: 8647159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of mammary tumor virus (Mtv)-negative and single-Mtv mice to evaluate the effects of endogenous viral superantigens on the T cell repertoire.
    Scherer MT; Ignatowicz L; Pullen A; Kappler J; Marrack P
    J Exp Med; 1995 Nov; 182(5):1493-504. PubMed ID: 7595219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of dendritic cells in the immune response induced by mouse mammary tumor virus superantigen.
    Baribaud F; Maillard I; Vacheron S; Brocker T; Diggelmann H; Acha-Orbea H
    J Virol; 1999 Oct; 73(10):8403-10. PubMed ID: 10482591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.